Novartis International AG

Tweet this page
<
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
>
Registration as it was on 28 Jun 2023
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

1,750,000€ - 1,999,999€

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

2 Fte (5)

Lobbyists with EP accreditation

5

High-level Commission meetings

30

Lobbying Costs over the years

  • Info

    Novartis International AG

    EU Transparency Register

    91269481588-28 First registered on 27 Apr 2009

    Goals / Remit

    Our mission is to discover new ways to improve and extend people's lives.
    We use science-based innovation to address some of society's most challenging healthcare issues.
    We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
    We also aim to provide a shareholder return that rewards those who invest their money, time and ideas in our company.

    Main EU files targeted

    Antimicrobial resistance (AMR), ATMP Regulation, Big data, Biosimilars & generics, Clinical Trials Regulation, Data Protection Regulation, EU IP policy, EU Relative Efficacy Assessment (EU REA), EU research policy, EU trade policy, Health Systems Performance Assessment, Health Technology Assessment & Market Access, Industrial policy, Innovative Medicines Initiative (IMI), Outcomes-based healthcare systems, Orphan Medicinal Products Regulation, Paediatric Regulation, Patient access to innovation, Patient safety, Pharmaceuticals in the environment, Sustainable Development Goals, Due Diligence

    Address

    Head Office
    Novartis International AG Forum 1
    Basel CH-4002
    SWITZERLAND
    EU Office
    Rue Belliard 40
    Brussels
    BELGIUM

    Website

  • People

    Total lobbyists declared

    5

    Employment timeLobbyists
    75%1
    50%1
    25%3

    Lobbyists (Full time equivalent)

    2

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    5 accreditations were / are live (in bold) for the selected state of 23 Feb 2024

    Name Start date End Date
    Ms Sarah MOUNDIR 30 Nov 2023 28 Nov 2024
    Ms Julie Chauvet 24 Nov 2023 22 Nov 2024
    Mr Christian Thonke 27 Oct 2023 25 Oct 2024
    Mr Wojciech Nowak 27 Oct 2023 25 Oct 2024
    Ms Véronique MASI 07 Jul 2023 18 Jan 2024
    Ms Aoiffe O'BRIEN 05 Jul 2023 04 Jul 2024
    Mr Vincent VANWIJNSBERGHE 05 Jul 2023 03 Oct 2023
    Ms Julie Chauvet 09 Nov 2022 09 Nov 2023
    Mr Arnaud MAHEAS 09 Sep 2022 30 Jun 2023
    Ms Elke Grooten 09 Aug 2022 30 Jun 2023
    Ms Sarah MOUNDIR 05 Aug 2022 05 Aug 2023
    Ms Julie Chauvet 19 Oct 2021 19 Oct 2022
    Ms Laura KOENE 23 Sep 2021 23 Sep 2022
    Ms Sarah MOUNDIR 04 Aug 2021 04 Aug 2022
    Ms Elke Grooten 15 Jul 2021 15 Jul 2022
    Ms Sarah MOUNDIR 03 Oct 2020 04 Aug 2021
    Ms Julie Chauvet 20 Feb 2020 01 Mar 2021
    Ms Ivana CATTANEO 20 Feb 2020 20 Feb 2021
    Mr Wojciech Nowak 20 Feb 2020 20 Feb 2021
    Ms Maria CARUSO 20 Feb 2020 01 Sep 2020
    Ms Elke Grooten 08 Jan 2020 08 Jan 2021
    Ms Tiziana DE FEO 23 Nov 2019 21 Nov 2020
    Mr Arnaud MAHEAS 07 Nov 2019 07 Nov 2020
    Ms Maria CARUSO 06 Sep 2019 20 Feb 2020
    Ms Ivana CATTANEO 08 Mar 2019 20 Feb 2020
    Mr Joerg Jenewein 20 Feb 2019 20 Feb 2020
    Ms Julie Chauvet 12 Feb 2019 12 Feb 2020
    Mr Maximilian Alexander GÖTZ VON OLENHUSEN 29 Jan 2019 06 Sep 2019
    Mr Wojciech Nowak 29 Jan 2019 01 Feb 2020
    Ms Francesca Maria RISSO 24 Jan 2019 24 Jul 2019
    Ms Gemma DIEZ LORENTE 18 Sep 2018 24 Jan 2019
    Ms ludovica moccaldi 13 Sep 2018 08 May 2019
    Ms Ivana CATTANEO 14 Mar 2018 08 Mar 2019
    Ms Gemma DIEZ LORENTE 14 Mar 2018 18 Sep 2018
    Ms Julie Chauvet 24 Feb 2018 12 Feb 2019
    Mr Maximilian Alexander GÖTZ VON OLENHUSEN 20 Jan 2018 19 Jan 2019
    Mr Joerg Jenewein 13 Dec 2017 13 Dec 2018
    Mr Florian Erny 27 Oct 2017 02 Jun 2018
    Ms Ivana CATTANEO 20 Sep 2017 14 Mar 2018
    Ms Elisa Balducci 08 Sep 2017 10 Jan 2018
    Mr Wojciech Nowak 31 Aug 2017 22 Aug 2018
    Ms Danielle Powell 20 Jul 2017 01 Aug 2017
    Ms ludovica moccaldi 20 May 2017 19 May 2018
    Ms Elisa Balducci 20 Mar 2017 07 Sep 2017
    Ms Julie Chauvet 28 Feb 2017 24 Feb 2018
    Mr Maximilian Alexander GÖTZ VON OLENHUSEN 23 Jan 2017 17 Jan 2018
    Mr Joerg Jenewein 01 Dec 2016 01 Dec 2017
    Mr Florian Erny 10 Nov 2016 27 Oct 2017
    Mr Wojciech Nowak 22 Aug 2016 30 Jul 2017
    Ms Nina Brkuljan 30 Jun 2016 29 Dec 2016
    Ms Marie Blanchard 23 Jun 2016 24 Jan 2017
    Mr Maximilian Alexander GÖTZ VON OLENHUSEN 08 Jan 2016 07 Jan 2017
    Mr Sture Alne 08 Jan 2016 07 Jul 2016
    Mr Joerg Jenewein 04 Dec 2015 01 Dec 2016
    Mr Florian Erny 18 Nov 2015 10 Nov 2016
    Ms Elke Grooten 16 Sep 2015 14 Sep 2016
    Ms Marie Blanchard 30 Jun 2015 23 Jun 2016
    Ms Claudia Gherman 06 May 2015 06 Jan 2016
    Ms Mathilde Panhaleux 12 Mar 2015 25 Apr 2015
    Mr Joaquin de Santos 10 Mar 2015 05 Sep 2015
    Ms Elke Grooten 06 Sep 2014 04 Sep 2015
    Mr Maximilian Alexander GÖTZ VON OLENHUSEN 13 Jan 2015 08 Jan 2016
    Mr Joerg Jenewein 18 Dec 2014 04 Dec 2015
    Ms Lea Pfefferle 11 Sep 2014 03 Mar 2015
    Mrs Elke Grooten 06 Sep 2014 27 Jan 2015
    Ms Emily Darrow 07 Aug 2014 12 Feb 2015
    Mr Brendan Moran 25 Jul 2014 29 Jan 2015
    Ms Marie Blanchard 04 Jul 2014 30 Jun 2015
    Mr Joaquin de Santos 11 Mar 2014 08 Mar 2015
    Ms Lea Pfefferle 08 Mar 2014 07 Sep 2014
    Mr Maximilian Alexander GÖTZ VON OLENHUSEN 23 Jan 2014 13 Jan 2015
    Mr Joerg Jenewein 07 Dec 2013 06 Dec 2014
    Ms Lea Pfefferle 06 Sep 2013 05 Mar 2014
    Ms Elisaveta Voynova 26 Jun 2013 12 Sep 2013
    Mr Joaquin de Santos 12 Apr 2013 11 Mar 2014
    Ms Elisaveta Voynova 26 Feb 2013 22 Jun 2013
    Mr Joaquin de Santos 26 Jan 2013 12 Apr 2013
    Mr Maximilian Alexander GÖTZ VON OLENHUSEN 06 Feb 2013 23 Jan 2014
    Mr Maximilian Alexander GÖTZ VON OLENHUSEN 07 Feb 2012 08 Feb 2013

    Complementary Information

    In 2022, 3 associate in the Brussels office spent between 25-75% on activities
    falling within the scope of the register.

    Two associates at global and regional headquarters spent up to 25 % of his/her time on activities falling within the scope of the register.

    Other associates involved on activities falling within the scope of the register spent less than 10% of their time on such activities.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    APIC (Sandoz), British Chamber, EACH, ECPA, EEASM (European Alliance for Access to Safe Medicines) + ASOP EU (Alliance for Safe Internet Pharmacy in the EU), EFPIA - Pillar 3 IMI, EFPIA (Pillar 1+2), EFPIA Oncology workstream (funded by Onco Region Europe), EFPIA CVD Workstream, EFPIA: Pillar 3 ICH;
    Eucope (Membership), Eucope Membership - Contribution to Incentives Steering Committee + SPC file, EuropaBio, Eurordis, Friends of Europe, GIRP, Kangaroo, Medicines for Europe (SDZ), Medicines for Europe Biosimilar Medicines (SDZ), Medicines for Europe VAM (previously EVA) (SDZ), Science Business Membership (BXL), Think Pink Europe, Transform (European Alliance on Transformative Therapies), Vital Transformation

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    1,750,000€ - 1,999,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    acumen 400,000€ - 499,999€
    fipra 10,000€ - 24,999€

    Intermediaries for current year

    Name
    acumen

    Closed year Costs

    1,750,000€ - 1,999,999€

    Other financial info

    We have calculated the estimate of annual costs related to activities covered by the register by adding our membership fees, event costs, consultancy fees together with facilities (rental charges) and personal costs.

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    None

    Other activities

    At European level, Novartis associates are active participants in the Structure Dialogue for security of medicines supplies.

  • Meetings

    Meetings

    30 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

Download this datacard